Any weight loss they experience is attributable to those co-treatments, not to GHK-Cu itself
Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial
Having both treatment options on a single platform means patients can connect with a Canadian licensed provider to make the right choice based on clinical needs and personal circumstances, not just what happens to be affordable
We start with baseline labs (fasting glucose, IGF-1, lipid panel, HbA1c), confirm there are no contraindications, and walk patients through the cycle structure and dosing protocol before any prescription is written
The increasing penetration of telemedicine, online pharmacies, and imminent biosimilar launches after patent expiration are making the service more accessible